The Pediatric LungRobert W. Wilmott Springer Science & Business Media, 1997 - 331 páginas Focussed specifically on children and pediatric respiratory diseases, "The Pediatric Lung+" reviews the current status of pharmacological therapy for asthma, viral pneumonia, cystic fibrosis, bronchopulmonary dysplasia and acute respiratory failure. A review of aerosol delivery systems in children and an up-to-date treatise on mucolytic agents is also included. The chapters are written by leading specialists in the field and summarize the latest developments in pediatric pulmonology, as well as covering a comprehensive range of respiratory diseases in children. Pediatric pulmonologists, allergologists, intensivists, neonatologists and general pediatricians will find "The Pediatric Lung" an invaluable source of reference. Clinicians will be particularly interested in the new information concerning aerosol delivery systems, gene therapy for cystic fibrosis, new modalities of therapy for asthma, the emerging role of nitric oxide and a treatise on modern mycolytic agents. |
Índice
IV | 2 |
VI | 3 |
VII | 4 |
VIII | 5 |
IX | 6 |
XII | 8 |
XIV | 9 |
XV | 10 |
155 | |
CXXXII | 156 |
CXXXIII | 157 |
CXXXV | 159 |
CXXXVI | 162 |
CXXXVII | 164 |
CXXXIX | 166 |
CXL | 167 |
XVI | 11 |
XVIII | 12 |
XIX | 14 |
XX | 15 |
XXII | 18 |
XXIII | 19 |
XXIV | 21 |
XXV | 22 |
23 | |
27 | |
XXIX | 28 |
XXX | 29 |
XXXI | 30 |
XXXV | 31 |
XXXVII | 34 |
XXXVIII | 35 |
XL | 36 |
41 | |
42 | |
XLIV | 43 |
XLVI | 44 |
XLVII | 46 |
XLVIII | 47 |
LI | 48 |
LIII | 49 |
LV | 50 |
LVII | 51 |
LVIII | 52 |
LX | 53 |
LXII | 54 |
LXIII | 55 |
LXVI | 56 |
LXVII | 57 |
LXVIII | 58 |
LXX | 59 |
LXXII | 60 |
LXXIV | 61 |
LXXV | 63 |
LXXVI | 64 |
LXXIX | 66 |
LXXX | 67 |
LXXXII | 68 |
LXXXIII | 69 |
LXXXIV | 70 |
LXXXVI | 71 |
83 | |
LXXXIX | 85 |
XC | 87 |
XCI | 89 |
XCII | 91 |
XCIV | 94 |
XCV | 95 |
XCVI | 98 |
XCVII | 99 |
XCVIII | 100 |
XCIX | 101 |
C | 102 |
CI | 105 |
CII | 106 |
CIII | 107 |
CV | 108 |
113 | |
CVII | 114 |
CVIII | 117 |
CIX | 118 |
CX | 120 |
CXIII | 126 |
CXIV | 127 |
CXV | 129 |
CXVI | 130 |
CXVII | 132 |
137 | |
CXX | 138 |
CXXII | 139 |
CXXIII | 141 |
CXXIV | 142 |
CXXV | 144 |
CXXVI | 145 |
CXXVII | 146 |
CXXVIII | 147 |
CXXIX | 149 |
CXLI | 169 |
CXLII | 171 |
CXLIII | 172 |
CXLV | 173 |
CXLVI | 174 |
CXLVII | 175 |
181 | |
CXLIX | 182 |
CL | 184 |
CLI | 186 |
CLIII | 187 |
CLIV | 191 |
CLV | 193 |
CLVI | 194 |
CLVII | 195 |
CLVIII | 196 |
199 | |
CLX | 200 |
CLXI | 201 |
CLXII | 203 |
CLXIV | 205 |
CLXV | 206 |
CLXVII | 207 |
CLXVIII | 208 |
CLXIX | 209 |
CLXXI | 210 |
CLXXII | 211 |
CLXXIV | 212 |
CLXXVII | 213 |
CLXXVIII | 214 |
229 | |
CLXXXI | 231 |
CLXXXII | 232 |
CLXXXIII | 234 |
CLXXXIV | 235 |
CLXXXV | 238 |
CLXXXVI | 239 |
CLXXXVII | 240 |
CLXXXVIII | 241 |
CLXXXIX | 244 |
CXC | 247 |
CXCI | 249 |
CXCII | 250 |
CXCIII | 251 |
259 | |
CXCVII | 260 |
CXCVIII | 261 |
CXCIX | 262 |
CC | 263 |
CCI | 264 |
CCII | 265 |
CCIII | 266 |
CCVI | 267 |
CCVIII | 272 |
CCIX | 273 |
274 | |
279 | |
CCXII | 282 |
CCXIII | 283 |
CCXIV | 284 |
CCXV | 285 |
CCXVII | 286 |
CCXVIII | 287 |
CCXX | 289 |
CCXXI | 290 |
CCXXII | 294 |
CCXXIII | 296 |
CCXXIV | 298 |
CCXXVI | 299 |
311 | |
CCXXXII | 312 |
CCXXXIII | 316 |
CCXXXV | 317 |
CCXXXVII | 318 |
CCXXXIX | 319 |
CCXL | 320 |
CCXLI | 322 |
CCXLII | 324 |
CCXLIII | 325 |
Otras ediciones - Ver todo
Términos y frases comunes
activity acute asthma adenovirus administration adults aerosol agents airway Allergy Clin Immunol alveolar amiloride antibodies asthma beclomethasone Biol bronchial bronchodilator bronchopulmonary dysplasia budesonide CFTR chloride chronic clearance clinical trials cromolyn sodium cystic fibrosis decrease delivery demonstrated deposition Dexamethasone dose drug effect efficacy Engl epithelial cells epithelium evaluation exogenous surfactant gene therapy gene transfer glucocorticoids human hypertension improvement increased infants infection inflammation inflammatory influenza inhaled corticosteroids inhibition inhibitors iNOS intravenous leukotriene lipid lung disease lung function mediators mucus mutations nasal nebuliser nebulized nedocromil nedocromil sodium neonatal neutrophil nitric oxide synthase oral particles patients with CF Pediatr peroxynitrite Pharmacol phospholipids Physiol placebo pneumonia prednisolone Pseudomonas pulmonary function receptor reduced Respir Crit respiratory distress response Rev Respir ribavirin role salbutamol secretions serum SP-A spacer sputum status asthmaticus steroids surfactant protein surfactant replacement systemic terbutaline tion tobramycin treatment vascular vector viral vitro vivo